FairScope Lab
EN 繁中 简中

PFE

Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

-

PEG Ratio

-

Dividend Yield

-

Gross Margin

69.97%

Net Margin

-9.39%

Revenue CAGR 3Y

-10.26%

ROE

-7.62%

ROA

-3.17%

Buyback Yield

0.49%

Current Ratio

1.16

Magic Earn Yield

-1.79%

Altman Z-Score

1.57

Fair Value River

Score

Valuation 0
Profitability 17
Growth 0
Health 35
Yield 8
← Back to Dashboard